The ratio of p-mTOR to total mTOR was 1.5-fold greater in placentae from IGF-1-treated fetuses compared with saline-treated IUGR fetuses (p = 0.06; Fig 5). The gene discussed is MTOR; the disease is fetal growth restriction.